News center

Owkin creates new spin out Waiv, formerly Owkin Dx, with $33m financing

Owkin Announces Partnership with Consensus to Strengthen Literature Intelligence for Owkin’s AI Scientist, K Pro

NHS Lothian joins Owkin’s patient data network with multi-year partnership

Global AI Impact Summit 2026, India: Owkin strengthens its strategic partnerships with India to advance biological artificial super intelligence

Owkin's Specialized Biological AI Agent Pathology Explorer Launches with Anthropic's Claude for Healthcare and Life Sciences

Owkin Brings Biology Super Intelligence Closer to Reality with New AI Infrastructure for Biological Breakthroughs

Owkin Advances Frontier Model Development for Biological Artificial Super Intelligence, Accelerated by NVIDIA

Les Echos features Owkin as a key AI partner for pharma

Owkin-Identified Biomarker-Defined Patient Subgroups In Phase 2 Trial Data Will Be Retrospectively Assessed By Servier

Owkin announces international validation results of BRCAura: AI-driven screening for gBRCA mutations directly from pathology slides

Université Paris-Saclay and Owkin: a unique alliance to propel university medical research to the top of the European rankings through AI

L'Opinion features Owkin about Franco-German initiative in AI-powered oncology